Fig 1.
a) The Parkinson’s KinetiGraph™ (The PKGTM, Global Kinetics Corporation) wrist-worn device. b) Chart presenting bradykinesia and dyskinesia by the time of the day, in comparison to the scores obtained in healthy controls (bold grey horizontal lines represent median scores in healthy controls) c) A raster plot presenting periods of tremor and d) immobility by the time of the day. Each black dot represents a 2-minute epoch. Reprinted from https://pkgcare.com/wp-content/uploads/2021/09/Whitepaper_The-Long-Term-Leader-in-Parkinsons-Disease-Enhancing-your-Clinical-Trial-Assessment-MM-96.pdf under a CC BY license, with permission, original copyright 2021.
Table 1.
Patients‘ demographic and clinical characteristics and the Parkinson’s KinetiGraph™ (PKGTM, Global Kinetics Corporation) scores.
Table 2.
Comparison of the demographic and clinical characteristics between the groups of the participants with and without fluctuation-related pain.
Fig 2.
Comparison of Parkinson’s KinetiGraph™ (the PKGTM, Global Kinetics Corporation) scores between the groups of the participants with and without fluctuation-related pain (FRP).
BKS—Bradykinesia Score, DKS—Dyskinesia Score, FDS–Fluctuation and Dyskinesia Score. Reprinted from https://pkgcare.com/wp-content/uploads/2021/09/Whitepaper_The-Long-Term-Leader-in-Parkinsons-Disease-Enhancing-your-Clinical-Trial-Assessment-MM-96.pdf under a CC BY license, with permission, original copyright 2021.
Table 3.
Results of univariate logistic regression.
Fig 3.
Multivariate logistic regression analysis identified a) the Fluctuation-Dyskinesia score (FDS) and b) the Bradykinesia Score (BKS) as significant predictors of fluctuation-related pain in People with Parkinson’s after the adjustment for Hoehn and Yahr Stage (H&Y) and the Scales for Outcomes in Parkinson’s disease–Motor Function (SCOPA-Motor) total score.